TechBBQ 2022

Casper Wilstrup moderates panel at TechBBQ

TechBBQ is the largest and most ‘hyggelig’ Scandinavian event supporting the Nordic startup ecosystem.

LSX Nordic Congress

Abzu panel at LSX Nordic Congress

The leading senior executive strategy, investment and partnering conference for the Nordic region.

Abzu® is named a “Cool Vendor” in the 2022 Gartner® Cool Vendors™ in AI Governance and Responsible AI — From Principles to Practice report

Abzu® is named a Cool Vendor in the 2022 Gartner® Cool Vendors in AI Governance and Responsible AI — From Principles to Practice report, an annual evaluation of commercial platforms for data science and machine learning (ML), as well as for cloud AI services platforms. These platforms use common open-source libraries for explainability, fairness, and trustworthiness, in addition to their own proprietary approaches.

Abzu appoints Mette Kirstine Agger as a member of the board

The Danish and Spanish AI company Abzu is bringing in an experienced force from biotech and venture-backed research, Mette Kirstine Agger, as a new member of their board. Mette Kirstine Agger was most recently Managing Partner for Lundbeckfonden Ventures, and with her experience in biotech and business development, she intends to strengthen Abzu’s position in the life sciences.

TechBBQ 2021

Casper Wilstrup speaking at TechBBQ 2021

Accelerating scientific discoveries with Abzu’s explainable AI: A breast cancer example

TechBBQ 2021

Jonas Wilstrup, CFO and COO Abzu, at TechBBQ

TechBBQ is the largest and most ‘hyggelig’ Scandinavian event supporting the Nordic startup ecosystem.

Record-breaking investment in groundbreaking Danish AI: Abzu announces a 5.8m € seed round

Denmark-based Abzu®, creator of a revolutionary high-performing, transparent, and explainable AI, has announced a 5.8 million euro seed round led by Seed Capital, Inventure, and PreSeed Ventures. Other notable participants in the round are existing investor Vaekstfonden and angel investors. The round follows Abzu’s increased traction with several of the world’s largest pharmaceutical companies.